The International Cell Surgical Society (ICSS) is a US-based, 501c3 nonprofit organization founded to promote autologous stem cell therapy and the advancement of regenerative medicine. The ICSS is dedicated to conducting and supporting education, research, and advancing knowledge and public awareness of stem cell therapy and regenerative medicine, as well as maintaining an effective Human Research Protection Program to protect the rights and welfare of human participants in research.
2013
46-1473917
$269 thousand
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

Supporting research on the use of fat-derived stem cells in spinal cord injury.

Managing an HHS registered Institutional Review Board to evaluate medical therapies.

Collaboration with Cell Surgical Network to host annual meetings on innovative techniques.
CSN Safety Data Publication
Published one of the largest peer-reviewed safety data papers on autologous SVF usage.
2017-03-01
The 4th Annual CSN Meeting in collaboration with Cell Surgical Network featuring leading clinicians.
2017-01-01
Approved study on cancer treatment for patients with solid tumors.
Overall Score
40
44
/100
Program Expense Ratio
96.25%
20
/20
Program Revenue Growth
34.44%
18
/20
Leverage Ratio
1.859
2
/20
Working Capital Ratio
-0.7245
2
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2023
Source:Source: Self-reported by organization
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 0 | 0.00% |
| Program Services | 301.1K | 100.00% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 301.1K | 100.00% |
Med Research
Surgical ResearchMed Research
Surgical ResearchMed Research
Surgical ResearchMed Research
Surgical ResearchMed Research
Surgical Research